Healthcare provider profile · identity verified

Jason David Lofton, MD

Family Practice · DE QUEEN, AR · NPI 1700892734

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	642	179
Lisinopril	Lisinopril	355	104
Levothyroxine Sodium	Levothyroxine Sodium	323	73
Amlodipine Besylate	Amlodipine Besylate	277	83
Pantoprazole Sodium	Pantoprazole Sodium	218	53
Gabapentin	Gabapentin	195	43
Losartan Potassium	Losartan Potassium	187	51
Metformin Hcl	Metformin Hcl	180	49
Potassium Chloride	Potassium Chloride	178	46
Hydrochlorothiazide	Hydrochlorothiazide	174	53
Carvedilol	Carvedilol	169	42
Escitalopram Oxalate	Escitalopram Oxalate	159	40
Furosemide	Furosemide	157	52
Prednisone	Prednisone	138	72
Naproxen	Naproxen	135	51
Omeprazole	Omeprazole	131	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	114	32
Sertraline Hcl	Sertraline Hcl	106	31
Metoprolol Succinate	Metoprolol Succinate	103	30
Tamsulosin Hcl	Tamsulosin Hcl	96	29
Clopidogrel	Clopidogrel Bisulfate	87	22
Tizanidine Hcl	Tizanidine Hcl	85	25
Memantine Hcl	Memantine Hcl	75	15
Fluticasone Propionate	Fluticasone Propionate	74	23
Eliquis	Apixaban	73	14
Metoprolol Tartrate	Metoprolol Tartrate	72	25
Allopurinol	Allopurinol	71	22
Mounjaro	Tirzepatide	69	14
Lovastatin	Lovastatin	65	23
Rosuvastatin Calcium	Rosuvastatin Calcium	65	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	59	13
Meloxicam	Meloxicam	59	18
Mirtazapine	Mirtazapine	56	13
Trazodone Hcl	Trazodone Hcl	55	16
Clonazepam	Clonazepam	54	15
Topiramate	Topiramate	52	suppressed
Tramadol Hcl	Tramadol Hcl	49	19
Alendronate Sodium	Alendronate Sodium	47	13
Simvastatin	Simvastatin	47	14
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Ropinirole Hcl	Ropinirole Hcl	44	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	44	39
Chlorthalidone	Chlorthalidone	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	16
Ozempic	Semaglutide	43	12
Glipizide	Glipizide	42	15
Trulicity	Dulaglutide	42	suppressed
Amoxicillin	Amoxicillin	41	22
Azithromycin	Azithromycin	38	25
Montelukast Sodium	Montelukast Sodium	38	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	37	37
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	11
Clonidine Hcl	Clonidine Hcl	31	12
Atenolol	Atenolol	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Albuterol Sulfate Hfa	Albuterol Sulfate	27	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	20
Pregabalin	Pregabalin	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Estradiol	Estradiol	25	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Famotidine	Famotidine	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Prasugrel Hcl	Prasugrel Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Ezetimibe	Ezetimibe	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Emgality Pen	Galcanezumab-Gnlm	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Elinest	Norgestrel-Ethinyl Estradiol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Methazolamide	Methazolamide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Nystatin	Nystatin	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Risperidone	Risperidone	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Valsartan	Valsartan	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Constulose	Lactulose	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error